Advanced Prostate Cancer VL

Lorelei Mucci and Philip Kantoff on Outcomes Research and the IRONMAN Project

Details
Lorelei Mucci and Phil Kantoff discuss the outcomes research of International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC) in St. Gallen, Switzerland. Alicia Morgans interviews Lorelei Mucci and Phil Kantoff to discuss the changing treatment landscape for treating prostate cancer and the goal of the IR...

Ian Tannock on the Global view of Advanced Prostate Cancer

Details
Ian Tannock, presented, "Best use of "old and cheap" drugs", at the 2017 Advanced Prostate Cancer Consensus Conference in St. Gallen, Switzerland. Dr. Tannock and Charles Ryan, MD, discuss the greatest challenges faced globally in terms of prostate cancer and the lack of resources. Also, Dr. Tannock shares his views on what clinicians can do to improve the cost of drugs and the importance of educa...

Oligometastatic and oligo-progressive prostate cancer- Oliver Sartor

Details
Biographies: Alicia Morgans Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Susan Halabi on Sub Group Analysis

Details
Susan Halabi presented, "Should we be lumpers or slicers?" as part of the castration-sensitive naive prostate cancer session at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC) in St. Gallen, Switzerland. Alicia Morgans, MD interviewed Susan on the utility of the sub group analysis and how clinicians need to think about those in clinical trials. In addition, a discussion around the v...

Mack Roach and Martin Spahn on 'Oligometastases: RP is experimental and should only be done in the context of a prospective clinical trial’ versus 'RP and SBRT to bone disease is a reasonable manageme...

Details
Dr. Mack Roach and Dr. Martin Spahn presented a debate on “Oligometastases: RP Is Experimental and Should Only Be Done in the Context of a Prospective Clinical Trial” versus “RP and SBRT to Bone Disease Is a Reasonable Management Strategy for Men with Oligomets” at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6) Biographies: Mack Roach III, MD Martin Spahn, MD , currently Senior Con...

Thomas Keane on Vitamin D and Prostate Cancer - STOP 6

Details
Prostate Cancer and Vitamin D (STOP 6) Biography: Thomas E. Keane, MBBCh, FRCSI, FACS

Piet Ost on The impact of local treatment of the prostate in patients with newly diagnosed metastatic prostate cancer - STOP 6

Details
The impact of local treatment of the prostate in patients with newly diagnosed metastatic prostate cancer (STOP 6) Biography: Piet Ost, MD, PhD is the adjunct head of the Radiation oncology clinic, part of the Ghent University Hospital. He is an assistant professor and part of the faculty of Medicie and Health Sciences at the University of Ghent. Dr. Ost is a member of the Steering Committee of IO...

Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223 - Noel Clarke

Details
This video lecture presentations took place at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), in Lisbon, Portugal between in October 2016. The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Noel Clarke, MD, discusses the biology of different bone targeted agents in metas...

Noel Clarke on Combination Treatment in Hormone-sensitive Prostate Cancer - STOP 6

Details
Combination Treatment in Hormone-sensitive Prostate Cancer (STOP 6) Biography: Noel Clarke, MD

Noel Clarke on Clinical applications of molecular genetics in prostate cancer - STOP 6

Details
Clinical applications of molecular genetics in prostate cancer (STOP 6) Biography: Noel Clarke, MD
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe